logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

The controlling shareholder of 263 (002467.SZ), Li Xiaolong, intends to reduce his shareholding by not more than 1%.

date
09/07/2025
China Fortune Financial App News, 263 (002467.SZ) announced that the company's controlling shareholder, Mr. Li Xiaolong, plans to reduce his holding of the company's shares by no more than 13.75 million shares (1% of the total share capital) through centralized bidding within three months after fifteen trading days from the date of this announcement.
Latest
3 m ago
The latest decrease in the stock prices of Ericsson and Nokia is 4.1% and 1.8% respectively.
5 m ago
The sheriff said that the death toll from flash floods in Kerr County, Texas has risen to 95 people.
5 m ago
The Swiss Medicines Agency announced on the 8th that it has approved the Swiss pharmaceutical company Novartis to produce the new-born anti-malaria drug Riamet Baby (also known as Coartem Baby) for marketing. This drug, developed specifically for newborns weighing 2-5 kilograms, fills a crucial gap in the field of malaria treatment, marking an important step forward in the global fight against malaria.
5 m ago
Switzerland has approved the marketing of antimalarial drugs for newborns.
6 m ago
Samsung releases Galaxy Z Fold7 phone, starting at a price of 13999 yuan for the Chinese market.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.